Ever Source Wealth Advisors, LLC Biomarin Pharmaceutical Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 634 shares of BMRN stock, worth $43,270. This represents 0.0% of its overall portfolio holdings.
Number of Shares
634
Previous 103
515.53%
Holding current value
$43,270
Previous $7,000
485.71%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BMRN
# of Institutions
626Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.55 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.32 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.24 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$1.01 Billion0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$887 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.7B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...